XML 54 R42.htm IDEA: XBRL DOCUMENT
v3.23.1

SEGMENT AND ENTERPRISE-WIDE INFORMATION (Tables) | 12 Months Ended
--- | ---
Apr. 01, 2023
Segment Reporting [Abstract] |
Selected Information by Business Segment |
(In thousands) | 2023 |  | 2022 |  | 2021
Net revenues |  |  |  |  |
Plasma | $ | 500,489 |  |  | $ | 351,945 |  |  | $ | 333,334 |
Blood Center | 289,365 |  |  | 294,541 |  |  | 307,370 |
Hospital | 378,206 |  |  | 321,580 |  |  | 210,606 |
Net revenues by business unit | 1,168,060 |  |  | 968,066 |  |  | 851,310 |
Service (1) | 21,424 |  |  | 20,811 |  |  | 20,758 |
Effect of exchange rates | (20,824) |  |  | 4,319 |  |  | (1,605) |
Net revenues | $ | 1,168,660 |  |  | $ | 993,196 |  |  | $ | 870,463 |
(1) Reflects revenue for service, maintenance and parts. |  |  |  |  |
(In thousands) | 2023 |  | 2022 |  | 2021
Segment operating income |  |  |  |  |
Plasma | $ | 278,580 |  |  | $ | 183,131 |  |  | $ | 172,463 |
Blood Center | 132,107 |  |  | 136,691 |  |  | 141,962 |
Hospital | 154,416 |  |  | 129,783 |  |  | 84,066 |
Segment operating income | 565,103 |  |  | 449,605 |  |  | 398,491 |
Corporate expenses (1) | (355,089) |  |  | (281,476) |  |  | (256,751) |
Effect of exchange rates | 8,419 |  |  | 18,993 |  |  | 12,830 |
Amortization of acquired intangible assets | (32,640) |  |  | (47,414) |  |  | (32,830) |
Impairment of assets and PCS2 related charges | 616 |  |  | (5,732) |  |  | (25,696) |
Integration and transaction costs | 411 |  |  | (21,604) |  |  | (18,421) |
Restructuring and restructuring related costs | (11,549) |  |  | (28,824) |  |  | (15,661) |
Digital transformation costs | (4,536) |  |  | — |  |  | — |
MDR and IVDR costs | (9,854) |  |  | (11,033) |  |  | (4,130) |
Litigation-related charges | (5,230) |  |  | (1,368) |  |  | (897) |
Gains on divestitures and sale of assets | 382 |  |  | 9,603 |  |  | 32,812 |
Operating income | $ | 156,033 |  |  | $ | 80,750 |  |  | $ | 89,747 |
(1) Reflects shared service expenses including quality and regulatory, customer and field service, research and development, manufacturing and supply chain, as well as other corporate support functions.
(In thousands) | 2023 |  | 2022 |  | 2021
Depreciation and amortization |  |  |  |  |
Plasma | $ | 41,612 |  |  | $ | 28,314 |  |  | $ | 24,093 |
Blood Center | 13,927 |  |  | 32,489 |  |  | 39,672 |
Hospital | 37,768 |  |  | 36,944 |  |  | 20,522 |
Total depreciation and amortization (excluding impairment charges) | $ | 93,307 |  |  | $ | 97,747 |  |  | $ | 84,287 |
(In thousands) | April 1, 2023 |  | April 2, 2022 |  |
Long-lived assets(1) |  |  |  |  |
Plasma | $ | 202,075 |  |  | $ | 129,241 |  |  |
Blood Center | 68,395 |  |  | 82,714 |  |  |
Hospital | 40,415 |  |  | 46,527 |  |  |
Total long-lived assets | $ | 310,885 |  |  | $ | 258,482 |  |  |
(1) Long-lived assets are comprised of property, plant and equipment.
Selected information by operating regions is presented below:
(In thousands) | April 1, 2023 |  | April 2, 2022 |  |
Long-lived assets(1) |  |  |  |  |
United States | $ | 251,812 |  |  | $ | 200,927 |  |  |
Japan | 997 |  |  | 1,096 |  |  |
Europe | 14,587 |  |  | 11,989 |  |  |
Asia | 26,263 |  |  | 28,132 |  |  |
Other | 17,226 |  |  | 16,338 |  |  |
Total long-lived assets | $ | 310,885 |  |  | $ | 258,482 |  |  |
(1) Long-lived assets are comprised of property, plant and equipment.
(In thousands) | 2023 |  | 2022 |  | 2021
United States | $ | 842,897 |  |  | $ | 639,322 |  |  | $ | 522,607 |
Japan | 61,295 |  |  | 75,562 |  |  | 77,676 |
Europe | 156,680 |  |  | 163,520 |  |  | 159,077 |
Asia | 104,135 |  |  | 110,802 |  |  | 105,820 |
Other | 3,653 |  |  | 3,990 |  |  | 5,283 |
Net revenues | $ | 1,168,660 |  |  | $ | 993,196 |  |  | $ | 870,463 |
Schedule of Revenues by Product Line | Net revenues by product line are as follows:
(In thousands) | 2023 |  | 2022 |  | 2021
Plasma products and services | 563,734 |  |  | 427,611 |  |  | 414,266 |
Blood Center products and services | 226,819 |  |  | 236,158 |  |  | 239,614 |
Hospital products and services | 378,107 |  |  | 329,427 |  |  | 216,583 |
Net revenues | $ | 1,168,660 |  |  | $ | 993,196 |  |  | $ | 870,463 |

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total revenues from reportable segments to the entity's consolidated revenues. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8924-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (a) -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e8906-108599 + Details
Name: | us-gaap_ReconciliationOfRevenueFromSegmentsToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of information concerning material long-lived assets (excluding financial instruments, customer relationships with financial institutions, mortgage and other servicing rights, deferred policy acquisition costs, and deferred taxes assets) located in identified geographic areas and/or the amount of revenue from external customers attributed to that country from which revenue is material. An entity may also provide subtotals of geographic information about groups of countries. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 41 -URI http://asc.fasb.org/extlink&oid=123359005&loc=d3e9038-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 220 -SubTopic 10 -Section S99 -Paragraph 2 -Subparagraph (SX 210.5-03.1) -URI http://asc.fasb.org/extlink&oid=123367319&loc=SL114868664-224227 + Details
Name: | us-gaap_ScheduleOfRevenuesFromExternalCustomersAndLongLivedAssetsByGeographicalAreasTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration